Treace Medical Concepts, Inc. (NASDAQ: TMCI) Q3 2025 Earnings Call Transcript November 7, 2025 ...
As of Friday, November 07, Treace Medical Concepts, Inc.’s TMCI share price has dipped by 43.66%, which has investors questioning if this is right time to buy.
Treace Medical Concepts, Inc. ('Treace' or the 'Company') (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...
Treace has pioneered and patented the Lapiplasty ® 3D Bunion Correction ® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the ...
HOUSTON – When you first think of bunions, you might assume that they are a problem that elderly women develop after years of squeezing their feet into narrow high heels. However, the reality is that ...
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming June 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit ...
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Treace Medical Concepts, Inc. has filed a lawsuit against Zimmer Biomet Holdings and Paragon 28, alleging infringement of four patents related to its Lapiplasty® 3D Bunion Correction® technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback